1. Home
  2. ILMN vs SATS Comparison

ILMN vs SATS Comparison

Compare ILMN & SATS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ILMN
  • SATS
  • Stock Information
  • Founded
  • ILMN 1998
  • SATS 2007
  • Country
  • ILMN United States
  • SATS United States
  • Employees
  • ILMN N/A
  • SATS N/A
  • Industry
  • ILMN Medical Specialities
  • SATS Telecommunications Equipment
  • Sector
  • ILMN Health Care
  • SATS Consumer Discretionary
  • Exchange
  • ILMN Nasdaq
  • SATS Nasdaq
  • Market Cap
  • ILMN 16.0B
  • SATS 17.8B
  • IPO Year
  • ILMN 2000
  • SATS 2007
  • Fundamental
  • Price
  • ILMN $103.03
  • SATS $71.22
  • Analyst Decision
  • ILMN Buy
  • SATS Buy
  • Analyst Count
  • ILMN 15
  • SATS 6
  • Target Price
  • ILMN $123.67
  • SATS $56.30
  • AVG Volume (30 Days)
  • ILMN 1.3M
  • SATS 9.6M
  • Earning Date
  • ILMN 11-03-2025
  • SATS 11-11-2025
  • Dividend Yield
  • ILMN N/A
  • SATS N/A
  • EPS Growth
  • ILMN N/A
  • SATS N/A
  • EPS
  • ILMN 7.91
  • SATS N/A
  • Revenue
  • ILMN $4,284,000,000.00
  • SATS $15,452,639,000.00
  • Revenue This Year
  • ILMN N/A
  • SATS N/A
  • Revenue Next Year
  • ILMN $2.76
  • SATS N/A
  • P/E Ratio
  • ILMN $13.06
  • SATS N/A
  • Revenue Growth
  • ILMN N/A
  • SATS N/A
  • 52 Week Low
  • ILMN $68.70
  • SATS $14.90
  • 52 Week High
  • ILMN $156.66
  • SATS $85.37
  • Technical
  • Relative Strength Index (RSI)
  • ILMN 57.64
  • SATS 67.00
  • Support Level
  • ILMN $95.12
  • SATS $68.92
  • Resistance Level
  • ILMN $104.22
  • SATS $73.58
  • Average True Range (ATR)
  • ILMN 3.33
  • SATS 4.58
  • MACD
  • ILMN 0.47
  • SATS -0.74
  • Stochastic Oscillator
  • ILMN 88.42
  • SATS 51.39

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

About SATS EchoStar Corporation

Satellite television provides the bulk of EchoStar's revenue. The firm serves about 5 million US satellite customers, about 10% of the traditional television market. It also serves 2 million customers under the Sling brand. EchoStar has also amassed an extensive portfolio of spectrum licenses and is building a nationwide wireless network. It acquired Sprint's prepaid business, serving approximately 7 million customers, primarily under the Boost brand. The firm has agreed to sell a portion of its wireless licenses to AT&T and will rely heavily on the AT&T network to serve customers. EchoStar's legacy businesses provide satellite telecom services and equipment to businesses and consumers, including about 800,000 internet customers.

Share on Social Networks: